These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 28631755

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Construction of a synthetic metabolic pathway for biosynthesis of 2,4-dihydroxybutyric acid from ethylene glycol.
    Frazão CJR, Wagner N, Rabe K, Walther T.
    Nat Commun; 2023 Apr 06; 14(1):1931. PubMed ID: 37024485
    [Abstract] [Full Text] [Related]

  • 6. Construction of a synthetic pathway for the production of 1,3-propanediol from glucose.
    Frazão CJR, Trichez D, Serrano-Bataille H, Dagkesamanskaia A, Topham CM, Walther T, François JM.
    Sci Rep; 2019 Aug 09; 9(1):11576. PubMed ID: 31399628
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Engineering E. coli for the biosynthesis of 3-hydroxy-γ-butyrolactone (3HBL) and 3,4-dihydroxybutyric acid (3,4-DHBA) as value-added chemicals from glucose as a sole carbon source.
    Dhamankar H, Tarasova Y, Martin CH, Prather KL.
    Metab Eng; 2014 Sep 09; 25():72-81. PubMed ID: 24954784
    [Abstract] [Full Text] [Related]

  • 9. Direct conversion of glucose to malate by synthetic metabolic engineering.
    Ye X, Honda K, Morimoto Y, Okano K, Ohtake H.
    J Biotechnol; 2013 Mar 10; 164(1):34-40. PubMed ID: 23246984
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Butyrate production in engineered Escherichia coli with synthetic scaffolds.
    Baek JM, Mazumdar S, Lee SW, Jung MY, Lim JH, Seo SW, Jung GY, Oh MK.
    Biotechnol Bioeng; 2013 Oct 10; 110(10):2790-4. PubMed ID: 23568786
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Engineering of Escherichia coli for Krebs cycle-dependent production of malic acid.
    Trichez D, Auriol C, Baylac A, Irague R, Dressaire C, Carnicer-Heras M, Heux S, François JM, Walther T.
    Microb Cell Fact; 2018 Jul 16; 17(1):113. PubMed ID: 30012131
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Enhanced biosynthesis of 3,4-dihydroxybutyric acid by engineered Escherichia coli in a dual-substrate system.
    Gao H, Gao Y, Dong R.
    Bioresour Technol; 2017 Dec 16; 245(Pt A):794-800. PubMed ID: 28926911
    [Abstract] [Full Text] [Related]

  • 17. Metabolic engineering of acetoin and meso-2, 3-butanediol biosynthesis in E. coli.
    Nielsen DR, Yoon SH, Yuan CJ, Prather KL.
    Biotechnol J; 2010 Mar 16; 5(3):274-84. PubMed ID: 20213636
    [Abstract] [Full Text] [Related]

  • 18. Microbial production of 2,3 butanediol from seaweed hydrolysate using metabolically engineered Escherichia coli.
    Mazumdar S, Lee J, Oh MK.
    Bioresour Technol; 2013 May 16; 136():329-36. PubMed ID: 23567699
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.